Ubtech Robotics Faces Pivotal Week as Rival Unitree’s IPO Tests Sector Sentiment
31.05.2026 - 17:43:16 | boerse-global.de
The Chinese humanoid robotics landscape is bracing for a seismic event. On 1 June, the Shanghai Stock Exchange will review the listing application of Ubtech’s direct competitor Unitree Robotics, which plans to sell at least 40.4 million new shares on the STAR Market at a target volume of 4.2 billion yuan (roughly US$590 million). Trading is expected to commence on 5 June, and the outcome stands to reshape valuations across the sector — including for Ubtech, which has seen its own shares come under heavy pressure.
Ubtech’s stock has been sliding for weeks. On Friday it dropped 5.59% to €11.41, breaching its 50-day moving average of €11.73. The decline accelerated the seven-day loss to 16.36%, leaving the year-to-date performance at a 21.32% deficit. The stock now trades 32.70% below its 52-week high of €16.95, set in October 2025. The 30-day annualised volatility stands at 55.99%, underscoring persistent uncertainty.
Against this backdrop, Ubtech is moving to strengthen its technological moat. The company recently established a joint venture, Xixuan Chuangzhi Technology, in Wuxi with initial registered capital of 100 million yuan. Partners include graphics-processor developer MetaX and components supplier Zhejiang Fenglong Electric. The JV will focus on developing specialised edge chips for embodied intelligence — processors designed to run complex AI workloads directly inside humanoid robots, reducing latency and reliance on cloud computing. The scope covers IC design, robotics research, and AI algorithm software development.
Should investors sell immediately? Or is it worth buying Ubtech Robotics?
The chip initiative aligns with Ubtech’s broader financial trajectory. In fiscal year 2025, revenue surged 53.3% to 2.01 billion yuan, powered by its full-size humanoid segment. Sales in that division jumped from 35.6 million yuan to 821 million yuan, with 1,079 units shipped — predominantly from the Walker S series for industrial use. The humanoid business now accounts for 41% of total revenue. Gross margin improved by nine percentage points to 37.7%, while the net loss narrowed 31.9% to 790 million yuan. Ubtech invested more than 500 million yuan in research and development last year, representing over 25% of revenue.
While Unitree is reportedly channelling 2 billion yuan of its IPO proceeds into robot “brain” development — large AI models and autonomous decision software — Ubtech is doubling down on industrial applications. At the World Smart Industry Expo in Tianjin, which opened on 28 May, Ubtech showcased its Walker S humanoid, designed for complex factory tasks. For the first time, the expo allocated a dedicated pavilion to humanoid robots and AI, reflecting the sector’s growing prominence.
The divergence in strategy is becoming clearer. Unitree has historically relied on optimised motion control and mechanical design for strong margins. Ubtech, by contrast, is pursuing vertical integration through proprietary chips and high-value industrial deployments. The chip JV could further support margins over the medium term, but investor scepticism persists. The stock’s technical picture remains fragile; reclaiming the 50-day average is the immediate hurdle. A successful Unitree IPO — especially at a high valuation — could re-rate the entire sector, while weak demand might send Ubtech’s shares testing the 200-day line. Monday’s regulatory decision will set the tone.
Ad
Ubtech Robotics Stock: New Analysis - 31 May
Fresh Ubtech Robotics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Ubtech Aktien ein!
FĂĽr. Immer. Kostenlos.
